Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses

Mariko Dacher, Miguel A. Morales, Pascale Pescher, Olivier Leclercq, Najma Rachidi, Eric Prina, Mathieu Cayla, Albert Descoteaux, Gerald F. Späth

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Summary: Leishmania parasites cause important human morbidity and mortality. Essential Leishmania genes escape genetic assessment by loss-of-function analyses due to lethal null mutant phenotypes, even though these genes and their products are biologically most significant and represent validated drug targets. Here we overcome this limitation using a facilitated null mutant approach applied for the functional genetic analysis of the MAP kinase LmaMPK4. This system relies on the episomal expression of the target gene from vector pXNG that expresses the Herpes simplex virus thymidine kinase gene thus rendering transgenic parasites susceptible for negative selection using the antiviral drug ganciclovir. Using this system we establish the genetic proof of LmaMPK4 as essential kinase in promastigotes. LmaMPK4 structure/function analysis by plasmid shuffle allowed us to identify regulatory kinase sequence elements relevant for chemotherapeutic intervention. A partial null mutant, expressing an MPK4 derivative with altered ATP-binding properties, showed defects in metacyclogenesis, establishing a first link of MPK4 function to parasite differentiation. The approaches presented here are broadly applicable to any essential gene in Leishmania thus overcoming major bottlenecks for their functional genetic analysis and their exploitation for structure-informed drug development.

Original languageEnglish
Pages (from-to)146-166
Number of pages21
JournalMolecular Microbiology
Volume93
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Leishmania
Parasites
Plasmids
Phosphotransferases
Essential Genes
Ganciclovir
Proteins
Thymidine Kinase
Simplexvirus
Pharmaceutical Preparations
Genes
Antiviral Agents
Adenosine Triphosphate
Morbidity
Phenotype
Gene Expression
Mortality

ASJC Scopus subject areas

  • Molecular Biology
  • Microbiology
  • Medicine(all)

Cite this

Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses. / Dacher, Mariko; Morales, Miguel A.; Pescher, Pascale; Leclercq, Olivier; Rachidi, Najma; Prina, Eric; Cayla, Mathieu; Descoteaux, Albert; Späth, Gerald F.

In: Molecular Microbiology, Vol. 93, No. 1, 2014, p. 146-166.

Research output: Contribution to journalArticle

Dacher, M, Morales, MA, Pescher, P, Leclercq, O, Rachidi, N, Prina, E, Cayla, M, Descoteaux, A & Späth, GF 2014, 'Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses', Molecular Microbiology, vol. 93, no. 1, pp. 146-166. https://doi.org/10.1111/mmi.12648
Dacher, Mariko ; Morales, Miguel A. ; Pescher, Pascale ; Leclercq, Olivier ; Rachidi, Najma ; Prina, Eric ; Cayla, Mathieu ; Descoteaux, Albert ; Späth, Gerald F. / Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses. In: Molecular Microbiology. 2014 ; Vol. 93, No. 1. pp. 146-166.
@article{fed9f0dbecda41999fb31be6450bf8ae,
title = "Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses",
abstract = "Summary: Leishmania parasites cause important human morbidity and mortality. Essential Leishmania genes escape genetic assessment by loss-of-function analyses due to lethal null mutant phenotypes, even though these genes and their products are biologically most significant and represent validated drug targets. Here we overcome this limitation using a facilitated null mutant approach applied for the functional genetic analysis of the MAP kinase LmaMPK4. This system relies on the episomal expression of the target gene from vector pXNG that expresses the Herpes simplex virus thymidine kinase gene thus rendering transgenic parasites susceptible for negative selection using the antiviral drug ganciclovir. Using this system we establish the genetic proof of LmaMPK4 as essential kinase in promastigotes. LmaMPK4 structure/function analysis by plasmid shuffle allowed us to identify regulatory kinase sequence elements relevant for chemotherapeutic intervention. A partial null mutant, expressing an MPK4 derivative with altered ATP-binding properties, showed defects in metacyclogenesis, establishing a first link of MPK4 function to parasite differentiation. The approaches presented here are broadly applicable to any essential gene in Leishmania thus overcoming major bottlenecks for their functional genetic analysis and their exploitation for structure-informed drug development.",
author = "Mariko Dacher and Morales, {Miguel A.} and Pascale Pescher and Olivier Leclercq and Najma Rachidi and Eric Prina and Mathieu Cayla and Albert Descoteaux and Sp{\"a}th, {Gerald F.}",
year = "2014",
doi = "10.1111/mmi.12648",
language = "English",
volume = "93",
pages = "146--166",
journal = "Molecular Microbiology",
issn = "0950-382X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses

AU - Dacher, Mariko

AU - Morales, Miguel A.

AU - Pescher, Pascale

AU - Leclercq, Olivier

AU - Rachidi, Najma

AU - Prina, Eric

AU - Cayla, Mathieu

AU - Descoteaux, Albert

AU - Späth, Gerald F.

PY - 2014

Y1 - 2014

N2 - Summary: Leishmania parasites cause important human morbidity and mortality. Essential Leishmania genes escape genetic assessment by loss-of-function analyses due to lethal null mutant phenotypes, even though these genes and their products are biologically most significant and represent validated drug targets. Here we overcome this limitation using a facilitated null mutant approach applied for the functional genetic analysis of the MAP kinase LmaMPK4. This system relies on the episomal expression of the target gene from vector pXNG that expresses the Herpes simplex virus thymidine kinase gene thus rendering transgenic parasites susceptible for negative selection using the antiviral drug ganciclovir. Using this system we establish the genetic proof of LmaMPK4 as essential kinase in promastigotes. LmaMPK4 structure/function analysis by plasmid shuffle allowed us to identify regulatory kinase sequence elements relevant for chemotherapeutic intervention. A partial null mutant, expressing an MPK4 derivative with altered ATP-binding properties, showed defects in metacyclogenesis, establishing a first link of MPK4 function to parasite differentiation. The approaches presented here are broadly applicable to any essential gene in Leishmania thus overcoming major bottlenecks for their functional genetic analysis and their exploitation for structure-informed drug development.

AB - Summary: Leishmania parasites cause important human morbidity and mortality. Essential Leishmania genes escape genetic assessment by loss-of-function analyses due to lethal null mutant phenotypes, even though these genes and their products are biologically most significant and represent validated drug targets. Here we overcome this limitation using a facilitated null mutant approach applied for the functional genetic analysis of the MAP kinase LmaMPK4. This system relies on the episomal expression of the target gene from vector pXNG that expresses the Herpes simplex virus thymidine kinase gene thus rendering transgenic parasites susceptible for negative selection using the antiviral drug ganciclovir. Using this system we establish the genetic proof of LmaMPK4 as essential kinase in promastigotes. LmaMPK4 structure/function analysis by plasmid shuffle allowed us to identify regulatory kinase sequence elements relevant for chemotherapeutic intervention. A partial null mutant, expressing an MPK4 derivative with altered ATP-binding properties, showed defects in metacyclogenesis, establishing a first link of MPK4 function to parasite differentiation. The approaches presented here are broadly applicable to any essential gene in Leishmania thus overcoming major bottlenecks for their functional genetic analysis and their exploitation for structure-informed drug development.

UR - http://www.scopus.com/inward/record.url?scp=84903468974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903468974&partnerID=8YFLogxK

U2 - 10.1111/mmi.12648

DO - 10.1111/mmi.12648

M3 - Article

C2 - 24823804

AN - SCOPUS:84903468974

VL - 93

SP - 146

EP - 166

JO - Molecular Microbiology

JF - Molecular Microbiology

SN - 0950-382X

IS - 1

ER -